These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 22909147)

  • 1. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
    Volpe M; Christian Rump L; Ammentorp B; Laeis P
    Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
    Chrysant SG; Littlejohn T; Izzo JL; Kereiakes DJ; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Am J Cardiovasc Drugs; 2012 Aug; 12(4):233-43. PubMed ID: 22799613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
    Lewin AJ; Izzo JL; Melino M; Lee J; Fernandez V; Heyrman R
    Drugs Aging; 2013 Jul; 30(7):549-60. PubMed ID: 23549909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
    Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort Study.
    Park SJ; Rhee SJ
    Adv Ther; 2020 Aug; 37(8):3500-3514. PubMed ID: 32557349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
    Calhoun DA; Lacourcière Y; Crikelair N; Jia Y; Glazer RD
    Curr Med Res Opin; 2013 Aug; 29(8):901-10. PubMed ID: 23721363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
    Kereiakes DJ; Chrysant SG; Izzo JL; Littlejohn T; Melino M; Lee J; Fernandez V; Heyrman R
    Cardiovasc Diabetol; 2012 Oct; 11():134. PubMed ID: 23110471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
    Volpe M; Miele C; Haag U
    Clin Drug Investig; 2009; 29(6):381-91. PubMed ID: 19432498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.
    Kreutz R; Ammentorp B; Laeis P; de la Sierra A
    J Clin Hypertens (Greenwich); 2014 Oct; 16(10):729-40. PubMed ID: 25243781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olmesartan medoxomil/amlodipine/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Drugs; 2011 Jan; 71(2):209-20. PubMed ID: 21275446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension.
    Kereiakes DJ; Chrysant SG; Izzo JL; Littlejohn T; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    J Clin Hypertens (Greenwich); 2012 Mar; 14(3):149-57. PubMed ID: 22372774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.
    Volpe M; de la Sierra A; Ammentorp B; Laeis P
    Adv Ther; 2014 May; 31(5):561-74. PubMed ID: 24760656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA; Shojaee A; Maa JF; Neutel JM
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
    Calhoun DA; Crikelair NA; Yen J; Glazer RD
    Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.